Gene Salkind - Mar 30, 2022 Form 4 Insider Report for GROVE, INC. (UPXI)

Role
Director, 10%+ Owner
Signature
/s/ Gene Salkind
Stock symbol
UPXI
Transactions as of
Mar 30, 2022
Transactions value $
$500,000
Form type
4
Date filed
4/1/2022, 02:42 PM
Previous filing
Dec 10, 2021
Next filing
Jul 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UPXI Common Stock Purchase $500K +125K $4.00 125K Mar 30, 2022 Trustee F1
holding UPXI Common Stock 2.35M Mar 30, 2022 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding UPXI Option Grant 27.8K Mar 30, 2022 Common 27.8K $1.53 Direct F2
holding UPXI Option Grant 50K Mar 30, 2022 Common 50K $4.18 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 125,000 shares were purchased at $4.00 per share in a private transaction through the Marital Trust GST subject U/W/O Leopold Salkind Gene Salkind, Trustee and considered indirect ownership of Gene Salkind
F2 27,778 options are vested and shall be exercisable for a price of $1.53 for 10 years from February 1, 2021 (the "Grant Date")
F3 16,667 options are vested and shall be exercisable for a price of $4.18 for 10 years from July 21, 2022 (the "Grant Date"). 33,333 options share vest on a monthly basis over a two year period and exercisable for a price of $4.18 per option share for a ten year period of 10 years from the Grant Date.
F4 2,352,941 previously purchased and are jointly owned with Catherine Salkind.